February 16, 2026
Headlines

Eli Lilly

Mounjaro top-selling drug India

Mounjaro Top-Selling Drug India October 2025 – Diabetes & Obesity Treatment

Daily Current Affairs07 mins

Mounjaro emerges as India’s top-selling drug in October 2025, targeting type 2 diabetes and obesity. Explore its sales, mechanism, and impact on India’s pharma market. “Mounjaro Emerges India’s Top-Selling Drug in October 2025” Unprecedented market success of Mounjaro In October 2025, Mounjaro — a medication developed and marketed by Eli Lilly and Company — surged…

Read More
Eli Lilly $1 Billion Telangana Investment

Eli Lilly $1 Billion Telangana Investment: Pharma Hub Expansion in Hyderabad

Daily Current Affairs05 mins

Eli Lilly invests $1 billion in Telangana to establish a state-of-the-art pharmaceutical hub in Hyderabad, boosting India’s global pharma supply chain and creating thousands of jobs. Eli Lilly’s $1 Billion Investment in Telangana’s Pharma Sector Introduction: Eli Lilly’s Strategic Expansion in Telangana Eli Lilly and Company, a leading global pharmaceutical firm, has announced a significant…

Read More
Top